Abstract
article 7 of the who code requires that the industry, that is, manufacturers and distributors, irrespective of any action taken by member states, is responsible “for monitoring their marketing practices conforming to the principles and aim of the Code and for taking steps to ensure that their conduct at every level conforms to them.”’ The code also proscribes, among other things, infant formula manufacturers and distributors from gaining market share by offering incentive bonuses or quotas set specifically for sale of breast-milk substitutes. However, the payment of bonus is permitted if it is “based on the overall sales by a company of other products marketed by it.”’ The industry representatives are disallowed to “perform educational functions in relation to pregnant women or mothers of young infants and young children.” However, they can be “used for other functions by the health care system at the request and written approval of the appropriate authority of the government concerned.”’ An evaluation of the code compliance by the infant formula industry is hampered by a variety of factors that makes all claims and counter-claims as to the industry compliance, or lack thereof, highly suspect.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.